Read More Pharma Industry News Thermo Fisher Scientific acquires Henogen from Novasep for €725m to expand viral vector manufacturing capabilities Thermo Fisher Scientific has completed the acquisition of Henogen, a viral vector manufacturing business previously owned by Groupe… bypharmanewsdailyJanuary 16, 2021